Codexis supplies varying quantities of its enzymes to pharmaceutical companies, from small to moderate quantities while they are optimizing their production processes, to larger quantities during later-stage clinical development and commercial scale drug production [REF].
Customers can send Codexis their materials to test against Codexis' existing libraries of enzymes.